proflavine has been researched along with amsacrine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chignell, CF; Cysyk, RL; Millar, DB; Sinha, BK | 1 |
Denny, WA; Feigon, J; Kearns, DR; Leupin, W | 1 |
Jenkins, TC; McConnaughie, AW | 1 |
Aravena, Mde L; Bruno, AM; Cabrera, M; Cascante, M; Cerecetto, H; González, M; Lavaggi, ML; López de Ceráin, A; Monge, A; Olea-Azar, C; Pachón, G; Pietrasanta, LI | 1 |
Baguley, BC; Ferguson, LR; Iwamoto, Y; Pearson, A | 1 |
Kreuzer, KN; Masurekar, M; Ripley, LS | 1 |
Doerr, CL; Harrington-Brock, K; Moore, MM | 1 |
Shall, S; Tavassoli, M; Tavassoli, MH | 1 |
8 other study(ies) available for proflavine and amsacrine
Article | Year |
---|---|
Synthesis and biological properties of some spin-labeled 9-aminoacridines.
Topics: Acridines; Animals; Cells, Cultured; DNA; Electron Spin Resonance Spectroscopy; Escherichia coli; Leukemia L1210; Nucleic Acid Conformation; Spin Labels | 1976 |
Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.
Topics: Antineoplastic Agents; Base Composition; Chemical Phenomena; Chemistry; DNA; Hydrogen Bonding; Intercalating Agents; Kinetics; Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 1984 |
Novel acridine-triazenes as prototype combilexins: synthesis, DNA binding, and biological activity.
Topics: Acridines; Animals; Antineoplastic Agents; Base Sequence; Cattle; Diminazene; DNA; Drug Design; Humans; Models, Molecular; Molecular Sequence Data; Thymus Gland; Triazenes; Tumor Cells, Cultured | 1995 |
Study of benzo[a]phenazine 7,12-dioxide as selective hypoxic cytotoxin-scaffold. Identification of aerobic-antitumoral activity through DNA fragmentation.
Topics: Animals; Antineoplastic Agents; Caco-2 Cells; Cell Hypoxia; Cell Line; Colonic Neoplasms; Cricetinae; DNA Damage; DNA Fragmentation; Humans; Phenazines | 2010 |
Photo-enhancement of the mutagenicity of 9-anilinoacridine derivatives related to the antitumour agent amsacrine.
Topics: Acridines; Aminoacridines; Amsacrine; Antineoplastic Agents; Dose-Response Relationship, Drug; Frameshift Mutation; Light; Mutagenicity Tests; Mutagens; Oxidation-Reduction; Proflavine; Salmonella typhimurium | 1992 |
The specificity of topoisomerase-mediated DNA cleavage defines acridine-induced frameshift specificity within a hotspot in bacteriophage T4.
Topics: Amsacrine; Base Sequence; DNA Damage; DNA Repair; DNA Topoisomerases, Type II; DNA, Viral; Frameshift Mutation; Molecular Sequence Data; Mutagenesis; Proflavine; T-Phages | 1991 |
Micronucleus, chromosome aberration, and small-colony TK mutant analysis to quantitate chromosomal damage in L5178Y mouse lymphoma cells.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoacridines; Amsacrine; Animals; Bleomycin; Chromosome Aberrations; Dactinomycin; Dimethyl Sulfoxide; DNA Damage; Doxorubicin; Hazardous Waste; Leukemia L5178; Leukemia, Experimental; Methylcholanthrene; Methylmethacrylate; Methylmethacrylates; Mice; Micronucleus Tests; Mutation; Nitrogen Mustard Compounds; Proflavine; Thymidine Kinase | 1989 |
Effect of DNA intercalators on poly(ADP-ribose) glycohydrolase activity.
Topics: Aminoacridines; Amsacrine; Animals; Chloroquine; Daunorubicin; DNA; Ellipticines; Ethacridine; Ethidium; Glycoside Hydrolases; Histones; Intercalating Agents; Kinetics; Proflavine; Swine; Thymus Gland; Tilorone | 1985 |